Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene for Glucocorticoid-Induced Bone Loss
NCT00371956Phase 4Completed
- Sponsor
- Tuen Mun Hospital
- Start
- Sep 2006
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoporosis comparing Raloxifene with Placebo (2 arms). Primary endpoints: Bone Mineral Density at 12 months and Bone Turnover Markers at 12 months. Started Sep 2006; status: completed.
02
Drugs
raloxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00371956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371956.